Immunodiagnostic Systems Hldgs PLC Stock Rating Reaffirmed by Panmure Gordon (IDH)
Immunodiagnostic Systems Hldgs PLC (LON:IDH)‘s stock had its “hold” rating restated by investment analysts at Panmure Gordon in a note issued to investors on Thursday. They currently have a GBX 600 ($10.03) price target on the stock. Panmure Gordon’s price objective would suggest a potential upside of 26.12% from the stock’s previous close.
Immunodiagnostic Systems Hldgs PLC (LON:IDH) opened at 492.00 on Thursday. Immunodiagnostic Systems Hldgs PLC has a 52 week low of GBX 422.00 and a 52 week high of GBX 593.00. The stock has a 50-day moving average of GBX 513.5 and a 200-day moving average of GBX 522.8.
IDH has been the subject of a number of other recent research reports. Analysts at Canaccord Genuity cut their price target on shares of Immunodiagnostic Systems Hldgs PLC from GBX 492 ($8.22) to GBX 478 ($7.99) in a research note on Tuesday, August 12th. They now have a “hold” rating on the stock. Separately, analysts at N+1 Singer downgraded shares of Immunodiagnostic Systems Hldgs PLC to a “sell” rating in a research note on Monday, August 4th. They now have a GBX 480 ($8.02) price target on the stock, down previously from GBX 525 ($8.78). Finally, analysts at FinnCap reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Monday, August 4th. They now have a GBX 500 ($8.36) price target on the stock. Six research analysts have rated the stock with a hold rating, Immunodiagnostic Systems Hldgs PLC presently has an average rating of “Hold” and a consensus price target of GBX 509.33 ($8.51).
Immunodiagnostic Systems Holdings plc (LON:IDH) is engaged in manufacturing and distributing medical diagnostic products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.